These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8122960)

  • 1. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.
    Artigas F; Perez V; Alvarez E
    Arch Gen Psychiatry; 1994 Mar; 51(3):248-51. PubMed ID: 8122960
    [No Abstract]   [Full Text] [Related]  

  • 2. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
    Artigas F
    Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of pindolol to potentiate antidepressant medication.
    Blier P; Bergeron R
    J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors plus pindolol.
    Isaac MT; Tome MB
    Lancet; 1997 Jul; 350(9073):288-9. PubMed ID: 9242815
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
    Bordet R; Thomas P; Dupuis B
    Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors plus pindolol. The REEP.
    Bordet R; Thomas P; Dupuis B
    Lancet; 1997 Jul; 350(9073):289. PubMed ID: 9242816
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute tryptophan depletion in depressed patients treated with a selective serotonin-noradrenalin reuptake inhibitor: augmentation of antidepressant response?
    Booij L; Van der Does AJ; Haffmans PM; Riedel WJ
    J Affect Disord; 2005 Jun; 86(2-3):305-11. PubMed ID: 15935252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies.
    Martinez D; Broft A; Laruelle M
    Biol Psychiatry; 2000 Oct; 48(8):844-53. PubMed ID: 11063979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
    Tome MB; Cloninger CR; Watson JP; Isaac MT
    J Affect Disord; 1997 Jul; 44(2-3):101-9. PubMed ID: 9241570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year real world prospective follow-up study of a major depressive episode of patients treated with paroxetine and pindolol or paroxetine for 6 weeks.
    Tome MB; Isaac MT
    Int Clin Psychopharmacol; 1998 Jul; 13(4):169-74. PubMed ID: 9727727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.
    Geretsegger C; Bitterlich W; Stelzig R; Stuppaeck C; Bondy B; Aichhorn W
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):141-6. PubMed ID: 18054209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze.
    Sela VR; Biesdorf C; Ramos DH; Zangrossi H; Graeff FG; Audi EA
    Neurosci Lett; 2011 May; 495(1):63-6. PubMed ID: 21421022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
    Meyer JH; Kapur S; Eisfeld B; Brown GM; Houle S; DaSilva J; Wilson AA; Rafi-Tari S; Mayberg HS; Kennedy SH
    Am J Psychiatry; 2001 Jan; 158(1):78-85. PubMed ID: 11136637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on "Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression".
    Anderson GM
    J Clin Psychopharmacol; 1996 Jun; 16(3):256-7. PubMed ID: 8784661
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.